These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20650440)

  • 21. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
    Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of financial barriers to pediatric cochlear implantation: impact of socioeconomic status on access and outcomes.
    Chang DT; Ko AB; Murray GS; Arnold JE; Megerian CA
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):648-57. PubMed ID: 20644058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of insurance status on outcomes after surgery for spinal metastases.
    Dasenbrock HH; Wolinsky JP; Sciubba DM; Witham TF; Gokaslan ZL; Bydon A
    Cancer; 2012 Oct; 118(19):4833-41. PubMed ID: 22294322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort.
    Anderson ML; Peterson ED; Brennan JM; Rao SV; Dai D; Anstrom KJ; Piana R; Popescu A; Sedrakyan A; Messenger JC; Douglas PS
    Circulation; 2012 Oct; 126(18):2190-9. PubMed ID: 22988009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of percutaneous coronary intervention for chronic total occlusions.
    Mehran R; Claessen BE; Godino C; Dangas GD; Obunai K; Kanwal S; Carlino M; Henriques JP; Di Mario C; Kim YH; Park SJ; Stone GW; Leon MB; Moses JW; Colombo A;
    JACC Cardiovasc Interv; 2011 Sep; 4(9):952-61. PubMed ID: 21939934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Payer status and access to laparoscopic subtotal colectomy for ulcerative colitis.
    Greenstein AJ; Romanoff AM; Moskowitz AJ; Sosunov EA; Khaitov S; Egorova NN
    Dis Colon Rectum; 2013 Sep; 56(9):1062-7. PubMed ID: 23929015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing primary PCI beyond "door to intervention time"--are we there yet?
    Kaluski E; Maher J; Gerula C; Tsai S; Randhawa P; Saric M; Oghlakian G; Alfano D; Palmaro J; Haider B; Klapholz M
    Cardiovasc Revasc Med; 2010; 11(2):84-90. PubMed ID: 20347797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program.
    Ryan J; Linde-Zwirble W; Engelhart L; Cooper L; Cohen DJ
    Circulation; 2009 Feb; 119(7):952-61. PubMed ID: 19204307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to Posthospitalization Acute Care Facilities is Associated with Payer Status for Open Abdominal Aortic Repair and Open Lower Extremity Revascularization in the Vascular Quality Initiative.
    Ulloa JG; Woo K; Tseng CH; Maggard-Gibbons M; Rigberg D
    Ann Vasc Surg; 2017 Jul; 42():1-10. PubMed ID: 28279729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.
    Lemesle G; Torguson R; Bonello L; de Labriolle A; Maluenda G; Ben-Dor I; Collins SD; Syed AI; Xue Z; Satler LF; Pichard AD; Waksman R
    EuroIntervention; 2011 Apr; 6(9):1053-9. PubMed ID: 21518676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insurance status and demographic and clinical factors associated with pharmacologic treatment of depression: associations in a cohort in Buenos Aires.
    Machnicki G; Dillon C; Allegri RF
    Value Health; 2011; 14(5 Suppl 1):S13-5. PubMed ID: 21839885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation.
    Rinfret S; Rodés-Cabau J; Bagur R; Déry JP; Dorais M; Larose E; Barbeau G; Gleeton O; Nguyen CM; Noël B; Proulx G; Roy L; Taillon I; De Larochellière R; Bertrand OF;
    Heart; 2013 Apr; 99(8):562-9. PubMed ID: 23434769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.